LY4005130

DRUG3 trials

Sponsors

Eli Lilly and Company

Conditions

Alopecia AreataHealthyNon-Segmental Vitiligo (NSV)Vitiligo

Phase 1

A Study of LY4005130 in Healthy Participants

CompletedNCT06690996

Eli Lilly and CompanyHealthy

Start: 2024-11-08End: 2026-04-28Updated: 2026-06-23

Phase 2

A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)

RecruitingNCT07533006

Eli Lilly and CompanyAlopecia Areata

Start: 2026-04-14End: 2027-10-01Target: 60Updated: 2026-09-08

A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo

RecruitingNCT07533019

Eli Lilly and CompanyNon-Segmental Vitiligo (NSV), Vitiligo

Start: 2026-04-14End: 2027-09-01Target: 66Updated: 2026-09-08